Stay updated on Fruquintinib Maintenance in Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib Maintenance in Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Fruquintinib Maintenance in Metastatic Colorectal Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content removal, particularly regarding a clinical study on fruquintinib for metastatic colorectal cancer, including detailed inclusion and exclusion criteria, which are crucial for understanding the study's parameters. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference37%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Fruquintinib Maintenance in Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib Maintenance in Metastatic Colorectal Cancer Clinical Trial page.